Smithfield Trust CO Cytokinetics Inc Transaction History
Smithfield Trust CO
- $1.89 Billion
- Q1 2024
A detailed history of Smithfield Trust CO transactions in Cytokinetics Inc stock. As of the latest transaction made, Smithfield Trust CO holds 155 shares of CYTK stock, worth $8,432. This represents 0.0% of its overall portfolio holdings.
Number of Shares
155
Previous 155
-0.0%
Holding current value
$8,432
Previous $13,000
15.38%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CYTK
# of Institutions
459Shares Held
108MCall Options Held
7.2MPut Options Held
6.2M-
Black Rock Inc. New York, NY12.4MShares$675 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$544 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.12MShares$279 Million0.22% of portfolio
-
Bank Of America Corp Charlotte, NC4.78MShares$260 Million0.03% of portfolio
-
State Street Corp Boston, MA4.52MShares$246 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $5.12B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...